Evidence map›Paper›PMID 8650224›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1996

Cell cycle-dependent modulation of telomerase activity in tumor cells.

X Zhu, R Kumar, M Mandal, N Sharma, H W Sharma, U Dhingra, J A Sokoloski, R Hsiao, R Narayanan

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 227 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Oxoisoaporphine as Potent Telomerase Inhibitor.Molecules (Basel, Switzerland) · 2016
    Article
  13. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  14. Article
  15. Review
  16. Article
  17. Role of TERRA in the regulation of telomere length.International journal of biological sciences · 2015
    Review
  18. Article
  19. Article
  20. DNA repair at telomeres: keeping the ends intact.Cold Spring Harbor perspectives in biology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

X ZhuDivision of Oncology, Roche Research Center, Hoffman-La Roche, Inc., Nutley, NJ 07110, USA.
R Kumar
M Mandal
N Sharma
H W Sharma
U Dhingra
J A Sokoloski
R Hsiao
R Narayanan
Pennsylvania State University · USLa Roche College · USYale University · US

Funding

GROWTH REGULATION BY INTERFERONS: ROLE OF RB PROTEINR01CA056564 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI KUMAR, RAKESH · 1992 to 1995
–
NCI NIH HHS CA 56564
6 · The paper itself

Abstract

Telomerase is a ribonucleoprotein complex that is thought to add telomeric repeats onto the ends of chromosomes during the replicative phase of the cell cycle. We tested this hypothesis by arresting human tumor cell lines at different stages of the cell cycle. Induction of quiescence by serum deprivation did not affect telomerase activity. Cells arrested at the G1/S phase of the cell cycle showed similar levels of telomerase to asynchronous cultures; progression through the S phase was associated with increased telomerase activity. The highest level of telomerase activity was detected in S-phase cells. In contrast, cells arrested at G2/M phase of the cell cycle were almost devoid of telomerase activity. Diverse cell cycle blockers, including transforming growth factor beta1 and cytotoxic agents, also caused inhibition of telomerase activity. These results establish a direct link between telomerase activity and progression through the cell cycle.

Indexed as

Cell CycleAntineoplastic AgentsHumansTelomeraseTransforming Growth Factor betaTumor Cells, CulturedAntineoplastic AgentsTelomeraseTransforming Growth Factor beta

Identifiers

PMID8650224
PMCPMC39194
OpenAlexW2015591824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.